InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
8
T+90 hit rate
55%
T+90 mean return
+1.8%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Davis George Eric, Chief Executive Officer. Director active across 1 company, notably Biomarin Pharmaceutical INC. In total, 24 filings have been logged. Breakdown: 0 buy · 8 sells. Total volume traded: €6.3m. History available since 30 April 2021. The latest transaction was disclosed on 14 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations24 total
16,249 shares@ US$69.4410.4% of flowCommon StockSEC:0001048477-25-000037:0
11,040 shares0Common StockSEC:0001048477-25-000015:0
40,850 shares@ US$63.1023.8% of flowCommon StockSEC:0001048477-24-000112:0
301 shares@ US$68.6460.2% of flowCommon StockSEC:0001048477-24-000075:0
24,602 shares@ US$88.3420.1% of flowCommon StockSEC:0001048477-24-000054:0
10,260 shares0Common StockSEC:0001048477-24-000048:0
20,840 shares0Common StockSEC:0001048477-24-000026:0
13,764 shares@ US$95.3012.2% of flowCommon StockSEC:0001048477-23-000059:0
11,000 shares@ US$89.42389.0% of flowCommon StockSEC:0001048477-23-000033:0
317 shares@ US$66.880.2% of flowCommon StockSEC:0001209191-23-030719:0
8,900 shares0Common StockSEC:0001567619-23-005292:0
20,200 shares0Common StockSEC:0001209191-23-014614:0
1,474 shares@ US$67.810.9% of flowCommon StockSEC:0001567619-23-003998:0
3,690 shares@ US$96.343.5% of flowCommon StockSEC:0001567619-22-015635:0
7,398 shares@ US$90.006.6% of flowCommon StockSEC:0001567619-22-013886:0
341 shares@ US$62.4070.0002% mcap1.5% of flowCommon StockSEC:0001567619-22-009494:0
2,669 shares@ US$37.460.0008% mcap7.1% of flowCommon StockSEC:0001567619-22-009054:0
6,129 shares@ US$81.290.0039% mcap34.4% of flowCommon StockSEC:0001567619-22-007415:0
11,040 shares0Common StockSEC:0001567619-22-007181:0
9,370 shares0Common StockSEC:0001567619-22-006716:0
5,518 shares@ US$76.690.0031% mcap27.2% of flowCommon StockSEC:0001567619-21-014415:0
5,518 shares@ US$76.693.6% of flowCommon StockSEC:0001567619-21-014415
341 shares@ US$62.4071.3% of flowCommon StockSEC:0001567619-21-009021
341 shares@ US$62.4070.0002% mcap1.3% of flowCommon StockSEC:0001567619-21-009021:0
24 of 24 declarations
About Davis George Eric
George Eric Davis serves as Executive Vice President and Chief Legal Officer at BIOMARIN PHARMACEUTICAL INC. He is responsible for managing legal affairs and regulatory compliance for the company. His expertise in business law enables him to effectively advise executives on complex issues.
